Ultima Genomics

Ultima Genomics is a DNA-sequencing technology company founded in 2016. The company focuses on making human genome sequencing faster and more affordable, aiming to enhance biological research and improve human health. Ultima has raised over $600 million in funding to support its mission. The flagship product, the UG 100 sequencing platform, was announced in 2022. This platform significantly reduces the cost of genome sequencing to $100, utilizing innovative open wafer technology and automation. It offers high throughput, capable of processing over 30,000 genomes per year, and supports various applications, including whole genome sequencing, single cell sequencing, and liquid biopsies. Ultima has partnered with several leading genomic service providers to expand access to its technology globally, enhancing its impact in drug development and diagnostic testing.